Managing inadequate response to initial anti-TNF therapy in rheumatoid arthritis: optimising treatment outcomes

Anti-tumour necrosis factors (anti-TNFs) are established as first-line biological therapy for rheumatoid arthritis (RA) with over two decades of accumulated clinical experience. Anti-TNFs have well established efficacy/safety profiles along with additional benefits on various comorbidities. However,...

Descripción completa

Detalles Bibliográficos
Autores principales: Taylor, Peter C., Matucci Cerinic, Marco, Alten, Rieke, Avouac, Jérôme, Westhovens, Rene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386864/
https://www.ncbi.nlm.nih.gov/pubmed/35991524
http://dx.doi.org/10.1177/1759720X221114101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386864/
https://www.ncbi.nlm.nih.gov/pubmed/35991524
http://dx.doi.org/10.1177/1759720X221114101

Ejemplares similares